Rationale for diphosphonate therapy in hypercalcemia of malignancy. Introduction.
D001859:Bone Neoplasms / Q000556:secondary; D012968:Etidronic Acid / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007668:Kidney / Q000503:physiopathology; D010010:Osteoclasts / Q000378:metabolism; D009384:Paraneoplastic Endocrine Syndromes / Q000188:drug therapy*
D012968:Etidronic Acid